Interaction of metformin with the vitamin K antagonist phenprocoumon

被引：0
|
作者：
Wijnen, J. [1 ]
Van de Riet, I [1 ]
Lijfering, W. M. [1 ]
Van der Meer, F. [1 ]
机构：
[1] LUMC, Leiden, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：823 / 824
页数：2
相关论文
共 50 条
  • [41] Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation
    Patti, Giuseppe
    Pecen, Ladislav
    Lucerna, Markus
    Huber, Kurt
    Rohla, Miklos
    Renda, Giulia
    Siller-Matula, Jolanta
    Ricci, Fabrizio
    Kirchhof, Paulus
    De Caterina, Raffaele
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (06): : 749 - +
  • [42] Non-Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulant Agents After Transcatheter Aortic Valve Replacement
    Alaour, Bashir
    Ferrari, Enrico
    Heg, Dik
    Tueller, David
    Pilgrim, Thomas
    Muller, Olivier
    Noble, Stephane
    Jeger, Raban
    Reuthebuch, Oliver
    Toggweiler, Stefan
    Templin, Christian
    Wenaweser, Peter
    Nietlispach, Fabian
    Taramasso, Maurizio
    Huber, Christoph
    Rof, Marco
    Windecker, Stephan
    Stortecky, Stefan
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (03) : 405 - 418
  • [43] The effect of subclinical hypothyroidism on vitamin K antagonist treatment
    Squizzato, Alessandro
    Galli, Luca
    van Zaane, Bregje
    Romualdi, Erica
    Stuijver, Danka J.
    Dentali, Francesco
    Ageno, Walter
    Gerdes, Victor E. A.
    THROMBOSIS RESEARCH, 2012, 129 (04) : 520 - 522
  • [44] CURRENT PRACTICE WITH VITAMIN-K ANTAGONIST THERAPY
    KAZMIER, FJ
    MAYO CLINIC PROCEEDINGS, 1974, 49 (12) : 918 - 922
  • [45] Vitamin K antagonist use in the elderly: special considerations
    Siguret, Virginie
    Pautas, Eric
    Gouin-Thibault, Isabelle
    FUTURE CARDIOLOGY, 2007, 3 (03) : 321 - 330
  • [46] Immunomodulatory effects of vitamin K-antagonist acenocoumarol
    Schroecksnadel, S.
    Jenny, M.
    Kurz, K.
    Schennach, H.
    Weiss, G.
    Fuchs, D.
    THROMBOSIS RESEARCH, 2012, 129 : S176 - S176
  • [47] Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome
    不详
    ANNALS OF INTERNAL MEDICINE, 2019, 171 (10) : I36 - I36
  • [48] Flaccid spontaneous paraplegia related to vitamin K antagonist
    Soufiani, Aida
    Ismaili, Nabila
    Bendagha, Nesma
    Mossadak, Ahlam
    Faroudy, Mamoune
    Sbihi, Ahmed
    PRESSE MEDICALE, 2010, 39 (09): : 1002 - 1005
  • [49] Vitamin K antagonist control in Eastern and Southeastern Asia
    Oh, S.
    Goto, S.
    Angchaisuksiri, P.
    Camm, A. J.
    Cools, F.
    Haas, S.
    Koretsune, Y.
    Lim, T. W.
    Accetta, G.
    Kakkar, A. K.
    EUROPEAN HEART JOURNAL, 2015, 36 : 544 - 544
  • [50] Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome
    Moll, Stephan
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (07) : 510 - 510
12345